Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Sarcoma SPOREs

Sarcomas represent a heterogeneous group of cancers that may stem from soft tissue (muscles, fat tissue), bone, cartilage, peripheral nerve sheets, or other connective tissues. Many of these tumors affect children and young adults, accounting for 15% of all pediatric cancers. The incidence for individual sarcoma types is rather low and all sarcoma types combined amount to approximately 13,520 new soft tissue sarcoma cases per year (American Cancer Society data for 2025). The estimated death rate for soft tissue sarcomas in 2025 is forecast to be about 5,420 patients.

MSKCC Sarcoma SPORE

University of Michigan Leiomyosarcoma SPORE

  • Reviewed:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Sarcoma SPOREs was originally published by the National Cancer Institute.”

Email